Antiangiogenesis studies

Ask Question Sign Guest book	About Lymphoma \| Advocacy & Art \| CAM & Life Style \| Clinical trials \| Doctors & Centers \| Guidelines at Diagnosis \| How to Help \| Research \| Side Effects \| Support \| Symptoms \| Tests \| Treatments	WebCasts

Clinical Trials > By Treatment type > Antiangiogenic agents

Last update: 10/18/2007

	Bevacizumab (anti-VEGF) TOPIC SEARCH: Mechanisms PubMed Outcome ASCO \| Medscape \| PubMed Safety ASCO \| PubMed
	Cilengitide (EMD 121974) TOPIC SEARCH: Mechanisms PubMed Outcome ASCO \| Medscape \| PubMed Safety ASCO \| PubMed
	CC-5013 (Lenalidomide/ Revlimid) TOPIC SEARCH: Mechanisms PubMed Outcome ASCO \| Medscape \| PubMed Safety ASCO \| PubMed
	FR901228 TOPIC SEARCH: Mechanisms PubMed Outcome ASCO \| Medscape \| PubMed Safety ASCO \| PubMed
	MS-275 TOPIC SEARCH: Mechanisms PubMed Outcome ASCO \| Medscape \| PubMed Safety ASCO \| PubMed
	Sorafenib (BAY 43-9006) TOPIC SEARCH: Mechanisms PubMed Outcome ASCO \| Medscape \| PubMed Safety ASCO \| PubMed
	Thalidomide TOPIC SEARCH: Mechanisms PubMed Outcome ASCO \| Medscape \| PubMed Safety ASCO \| PubMed